Peginterferon beta-1a versus other self-injectable disease-modifying therapies in the treatment of relapsing-remitting multiple sclerosis in Scotland: a cost-effectiveness analysis. [electronic resource]

By: Contributor(s): Producer: 20170807Description: 228-238 p. digitalISSN:
  • 1941-837X
Subject(s): Online resources: In: Journal of medical economics vol. 20
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.